JOINT FILING AGREEMENT
EXHIBIT
1
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as
amended, the undersigned hereby agree to the joint filing with all other
Reporting Persons (as such term is defined in the Schedule 13D referred to
below) on behalf of each of them of a statement on Schedule 13D (including
amendments thereto) with respect to the common stock, par value $0.001 per
share, of Vanda Pharmaceuticals Inc., and that this Agreement be included as an
Exhibit to such joint filing. The Agreement may be executed in any
number of counterparts all of which taken together shall constitute one and the
same instrument.
IN
WITNESS WHEREOF, the undersigned hereby execute this Agreement this 6th day of
October, 2008.
| Tang Capital Partners, LP | |||
| By: | Tang Capital Management, LLC | ||
| By: | /s/ Xxxxx X. Xxxx | ||
| Xxxxx X. Xxxx, Manager | |||
| Tang Capital Management, LLC | |||
| By: |
/s/ Xxxxx X.
Xxxx
|
||
| Xxxxx X. Xxxx, Manager | |||
| /s/ Xxxxx X. Xxxx | |||
| Xxxxx X. Xxxx | |||
